Previous close | 0.2200 |
Open | 0.2000 |
Bid | 0.0500 |
Ask | 0.1800 |
Strike | 105.00 |
Expiry date | 2024-05-10 |
Day's range | 0.1400 - 0.2700 |
Contract range | N/A |
Volume | |
Open interest | 257 |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.